Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13784594 | 0.88 | ELANE (0.48) | ALDH1A1TSHRELANEKMT2AATM | |
| SCHEMBL22074734 | 0.87 | ELANE (0.50) | ALDH1A1TSHRELANEKMT2AATM | |
| SCHEMBL3087898 | 0.86 | ESR1 (0.50) | ALDH1A1TSHRELANEKMT2AATM | |
| SCHEMBL4122942 | 0.85 | ELANE (0.55) | ALDH1A1TSHRELANEKMT2AATM | |
| SCHEMBL13784596 | 0.85 | ELANE (0.46) | ALDH1A1TSHRELANEKMT2AATM | |
| SCHEMBL25784257 | 0.83 | TSHR (0.45) | ALDH1A1TSHRELANEKMT2AMEN1 | |
| SCHEMBL12286433 | 0.83 | ALDH1A1 (0.51) | ALDH1A1TSHRKMT2AMEN1TDP1 | |
| SCHEMBL4594842 | 0.83 | ELANE (0.56) | ALDH1A1ELANEKMT2AATMMEN1 | |
| SCHEMBL111718 | 0.83 | TSHR (0.60) | ALDH1A1TSHRELANEKMT2AMEN1 | |
| SCHEMBL15221808 | 0.81 | ELANE (0.54) | ALDH1A1TSHRELANEKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1740235-B1 | COATING COMPOSITIONS FOR BIOACTIVE AGENTS | SURMODICS INC (US) | 2009-07-22 | — | — | EP | claimed |
| US-7544673-B2 | Coating compositions for bioactive agents | SURMODICS, INC. (US) | 2009-06-09 | — | — | US | claimed |
| US-7541048-B2 | Coating compositions for bioactive agents | SURMODICS, INC. (US) | 2009-06-02 | — | — | US | claimed |
| JP-2007532187-A | — | — | 2007-11-15 | — | — | JP | claimed |
| EP-1740235-A1 | COATING COMPOSITIONS FOR BIOACTIVE AGENTS | SurModics, Inc. (US) | 2007-01-10 | — | — | EP | claimed |
| US-20050244459-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-11-03 | — | — | US | claimed |
| WO-2005099787-A1 | COATING COMPOSITIONS FOR BIOACTIVE AGENTS | SURMODICS, INC. (US) | 2005-10-27 | — | — | WO | claimed |
| WO-2005099786-A1 | COATING COMPOSITIONS FOR BIOACTIVE AGENTS | SURMODICS, INC. (US) | 2005-10-27 | — | — | WO | claimed |
| US-20050220840-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220841-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220843-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220839-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220842-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-9726798-B2 | Optical film, polarizing plate, and method for producing optical film | FUJIFILM CORPORATION (JP) | 2017-08-08 | — | — | US | disclosed |
| EP-2265293-B1 | COATING SYSTEMS FOR THE CONTROLLED DELIVERY OF HYDROPHILIC BIOACTIVE AGENTS | SURMODICS INC (US) | 2015-11-04 | — | — | EP | disclosed |
| US-20150277006-A1 | OPTICAL FILM, POLARIZING PLATE, AND METHOD FOR PRODUCING OPTICAL FILM | FUJIFILM CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20050220840-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | disclosed |
| US-20050220841-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | disclosed |
| US-20050220843-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | disclosed |
| US-20050220839-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050220839-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885 |
| US-20050220841-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885 |
| US-20050220843-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885 |
| US-20050220842-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885 |
| US-20050220840-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.